Aceragen, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Exton, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aceragen, Inc. has filed 1,698 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 851-875 of 985 matching filings.

Per page
25
Current page
35
SC 13G/A File 005-50211

IDERA PHARMACEUTICALS, INC.

Filing date
26 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50211

IDERA PHARMACEUTICALS, INC.

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31918

FORM 8-K

Filing date
11 Feb 2013
Reporting date
05 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-186312

EFFECT filing

Filing date
08 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-186312

FORM S-3

Filing date
30 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-185392

EFFECT filing

Filing date
17 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-185392

AMENDMENT NO. 1 TO FORM S-3

Filing date
15 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31918

FORM 8-K

Filing date
15 Jan 2013
Reporting date
15 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-185392

FORM S-3

Filing date
11 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31918

FORM 8-K

Filing date
07 Dec 2012
Reporting date
05 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31918

FORM 8-K

Filing date
30 Nov 2012
Reporting date
26 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

MAIN DOCUMENT DESCRIPTION

Filing date
19 Nov 2012
Reporting date
09 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

MAIN DOCUMENT DESCRIPTION

Filing date
19 Nov 2012
Reporting date
09 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-50211

SCHEDULE 13D/A

Filing date
16 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
15 Nov 2012
Reporting date
09 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
15 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
15 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
15 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
15 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31918

8-K

Filing date
14 Nov 2012
Reporting date
09 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2012
Reporting date
02 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .